Skip to content
DataLookout
Menu

NCT05724121

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

The 50 most recent of 125 versions: 2 with changes below, 48 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment closed, study ongoing
    • Final enrollment: 75 participants (planned 135)
    • Site details revised
  2. Notable Eligibility criteria expanded, about 7 words
    • Study description expanded, about 15 words
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

arrhythmogenic cardiac effects of BTKi and sudden death within the first 12 months of BTKi therapy
Timeframe: 12 months

Secondary (1)

tests for identifying and monitoring cardiac arrhythmias in patients receiving BTKi

Arms and interventions

Cohort A

includes all patients prior to starting therapy with a BTKi

Cohort B

includes all patients already on therapy with a BTKi

Cohort C

includes all patients prior to starting therapy with venetoclax

Sites

1 site in 1 country

  • National Institutes of Health Clinical CenterBethesda, Maryland, United States